Psychological Distress and Somatization in Immigrants in Primary Health Care Practices

García-Sierra, Rosa; Fernández-Cano, María Isabel; Manresa-Domínguez, Josep María; Feijoo-Cid, María; Moreno-Gabriel, Eduard; Marañón, Antonia Arreciado; Ramos-Roure, Francesc; Segura-Bernal, Jordi; Torán-Monserrat, Pere

doi:10.20944/preprints202011.0391.v1

Cited by 1 publication

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This item was intended to assess somatization, although the question was indirect and inaccurate. Somatization is thought to be seen when adaptive coping, such as verbalization and exercise is not carried out (García-Sierra et al, 2020). Poorer ability to develop an alternative coping strategy during the pandemic, such as online meetings and alternative exercise among F 2 patients may have resulted in their somatic symptoms.…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 pandemic on patients with mental health problems and the differences among diagnostic categories

Mashima

Koizumi

Minegishi

et al. 2022

Int J Soc Psychiatry

View full text Add to dashboard Cite

Background: The coronavirus disease 2019 (COVID-19) pandemic has resulted in a total upending of our daily lives. While anxiety and depression were frequently reported among the general population, the pandemic’s impact on patients with mental health problems remains unknown. Methods: A cross-sectional questionnaire survey involving 1,166 patients was conducted at one psychiatric hospital and one mental health clinic. Results: Symptom deterioration was reported in 23% to 34% of the patients and 9% to 20% reported increase in drug dosage. No significant differences were reported in these items among diagnostic categories. Patients with F3 (mood disorders) reported more psychological stress during the pandemic’s beginning and during the emergency. Patients with F2 (schizophrenia, schizotypal, and delusional disorders) did online shopping and meetings less frequently, and reported poorer adherence of 3C’s, while mask management was stricter in patients with F4 (neurotic, stress-related, and somatoform disorders). Symptom deterioration was significantly associated with increase in drug dosage, new physical symptoms, anxiety unrelated to COVID-19, stress at the beginning of pandemic, stress during the ‘state of emergency’, poor adaptability to environmental change, daily life changes, decrease in sleeping time, and decrease in time spent outside. Conclusion: One third of patients reported symptom deterioration during the pandemic, which was associated with stress and daily life changes. Patients with good adaptability to environmental changes might resilient against symptom deterioration. Providing continuous support to help patients manage their daily life in this COVID-19 era may minimize the risk of symptom deterioration.

show abstract

Section: Discussionmentioning

confidence: 99%